探索可光开关的结合相互作用与基于小分子和的素抑制剂
Kathryn A Palasis1, Victoria Peddie1, Dion J L Turner1
1ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), Institute for Photonics and Advanced Sensing (IPAS), Department of Chemistry, The University of Adelaide, North Terrace, Adelaide, SA 5005, Australia.
Chembiochem : a European journal of chemical biology
|August 16, 2023
概括
设计可光切换药物需要优化异构体之间的活性差异. 辐射时结合基因的显著结构变化是最大化这种差异的关键,这对于临床应用至关重要.
科学领域:
- 药用化学 医学化学
- 摄影化学的使用.
- 药物设计 药物设计
背景情况:
- 可光切换药物提供精确的时间和空间激活.
- 优化异构体状态之间的生物活性差异对于疗效至关重要.
- 了解可光切换药物向相互作用对于临床翻译至关重要.
研究的目的:
- 为了研究可光切换的小分子和抑制剂如何与它们的生物标相互作用,试.
- 为了比较小分子和基抑制剂之间的异构活性差异.
- 确定设计原则,以提高可光切换药物的疗效.
主要方法:
- 小分子和基于的素抑制剂的合成和表征.
- 光化学激活和评估不同异构体状态的抑制活性.
- 分子对接和3D结构建模以分析结合相互作用.
主要成果:
- 最好的抑制剂在异构体之间的抑制活性上显示了超过5倍的差异.
- 最好的小分子抑制剂在活性方面表现出3.4倍的差异.
- 分子建模表明,与小分子抑制剂不同的是,抑制剂的结合残留在异构化时发生了显著的结构变化.
结论:
- 在光异构化过程中,关键结合基因的显著结构重组对于最大限度地提高生物活性差异至关重要.
- 基于的抑制剂可能比小分子提供优势,以实现更大的异构体活性调节.
- 这些发现为下一代可光切换疗法的合理设计提供了关键的见解.
相关概念视频
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K


